Chronic stable angina: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
==Classification== | ==Classification== | ||
Classic: [[Chronic stable angina definition|Chronic | Classic: [[Chronic stable angina definition|Chronic Stable Angina]] | ||
Atypical: [[Chronic stable angina clinical subset- walk through angina pectoris|Walk through | Atypical: [[Chronic stable angina clinical subset- walk through angina pectoris|Walk through Angina]] | [[Chronic stable angina clinical subset- mixed angina pectoris|Mixed Angina]] | [[Chronic stable angina clinical subset- nocturnal angina pectoris|Nocturnal Angina]] | [[Chronic stable angina clinical subset- postprandial angina pectoris|Postprandial Angina]] | [[Chronic stable angina clinical subset- syndrome X|Syndrome X]] | [[Coronary Vasospasm|Vasospastic Angina]] | ||
== [[Chronic stable angina differential diagnosis|Differentiating | == [[Chronic stable angina differential diagnosis|Differentiating Chronic Stable Angina from Acute Coronary Syndromes]] == | ||
==[[Chronic stable angina pathophysiology|Pathophysiology]]== | ==[[Chronic stable angina pathophysiology|Pathophysiology]]== | ||
Line 22: | Line 22: | ||
==[[Chronic stable angina risk stratification|Risk Stratification]]== | ==[[Chronic stable angina risk stratification|Risk Stratification]]== | ||
[[Chronic stable angina risk stratification electrocardiogram/chest x-ray|ECG/Chest X-Ray]] | [[Chronic stable angina risk stratification based upon rest left ventricular function|Rest LV Function]] | [[Chronic stable angina risk assessment in patients with an intermediate or high probability of coronary artery disease|Exercise Treadmill Test]] | [[Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise|Stress | [[Chronic stable angina risk stratification electrocardiogram/chest x-ray|ECG/Chest X-Ray]] | [[Chronic stable angina risk stratification based upon rest left ventricular function|Rest LV Function]] | [[Chronic stable angina risk assessment in patients with an intermediate or high probability of coronary artery disease|Exercise Treadmill Test]] | [[Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise|Stress Imaging in Patients who are Able to Exercise]] | [[Chronic stable angina risk stratification cardiac stress imaging in patients who are unable to exercise|Stress Imaging in Patients who are Unable to Exercise]] | [[Chronic stable angina risk stratification coronary angiography|Coronary Angiography]] | ||
==[[Chronic stable angina probability of coronary artery disease| Pretest | ==[[Chronic stable angina probability of coronary artery disease| Pretest Probability of CAD in the Patient with Angina]]== | ||
==[[Chronic stable angina prognosis|Prognosis]]== | ==[[Chronic stable angina prognosis|Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Chronic stable angina symptoms|History and Symptoms]] | [[Chronic stable angina physical examination|Physical Examination]] | [[Chronic stable angina test selection guideline for the individual basis|Test | [[Chronic stable angina symptoms|History and Symptoms]] | [[Chronic stable angina physical examination|Physical Examination]] | [[Chronic stable angina test selection guideline for the individual basis|Test Selection Guideline for the Individual Basis]] | [[Chronic stable angina initial laboratory tests|Laboratory Findings]] | [[Chronic stable angina electrocardiography|Electrocardiography]] | [[Chronic stable angina exercise electrocardiography|Exercise ECG]] | [[Chronic stable angina chest x-ray|Chest X-Ray]] | [[Chronic stable angina perfusion scintigraphy with pharmacologic stress|Myocardial Perfusion Scintigraphy with Pharmacologic Stress]] | [[Chronic stable angina myocardial perfusion scintigraphy|Myocardial Perfusion Scintigraphy with Thallium]] | [[Chronic stable angina echocardiography|Echocardiography]] | [[Chronic stable angina exercise echocardiography|Exercise Echocardiography]] | [[Chronic stable angina positron emission tomography (PET)|Positron Emission Tomography]] | [[Chronic stable angina ambulatory ST segment monitoring|Ambulatory ST Segment Monitoring]] | [[Chronic stable angina electron beam tomography|Electron Beam Tomography]] | [[Chronic stable angina cardiac magnetic resonance imaging|Cardiac Magnetic Resonance Imaging]] | [[Chronic stable angina coronary angiography|Coronary Angiography]] | ||
==[[Chronic stable angina treatment|Treatment]]== | ==[[Chronic stable angina treatment|Treatment]]== | ||
Line 36: | Line 36: | ||
:Antiplatelet agents: [[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]] | :Antiplatelet agents: [[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]] | ||
:Antianginal agents: [[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium | :Antianginal agents: [[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium Channel Openers]] | [[Chronic stable angina newer antianginal agents|Newer Anti-anginal Agents]] | ||
:[[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEI/RAAS | :[[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEI/RAAS Blockers]] | ||
:[[Chronic stable angina treatment anti-lipid agents|Anti-lipid | :[[Chronic stable angina treatment anti-lipid agents|Anti-lipid Agents]] | ||
:[[Chronic stable angina guidelines for pharmacotherapy to improve prognosis and reduce symptoms|Guidelines for Pharmacotherapy]] | :[[Chronic stable angina guidelines for pharmacotherapy to improve prognosis and reduce symptoms|Guidelines for Pharmacotherapy]] | ||
Line 54: | Line 54: | ||
==[[Chronic stable angina secondary prevention|Secondary Prevention]]== | ==[[Chronic stable angina secondary prevention|Secondary Prevention]]== | ||
[[Chronic stable angina treatment smoking cessation|Smoking | [[Chronic stable angina treatment smoking cessation|Smoking Cessation]] | [[Chronic stable angina treatment weight management|Weight Management]] | [[Chronic stable angina treatment physical activity|Physical Activity]] | [[Chronic stable angina treatment lipid management|Lipid Management]] | [[Chronic stable angina treatment blood pressure control|BP Control]] | [[Chronic stable angina treatment diabetes control|Diabetes Control]] | [[Chronic stable angina treatment influenza vaccination|Influenza Vaccination]] | [[Chronic stable angina treatment ACC/AHA guidelines for cardiovascular risk factor reduction|ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction]] | ||
==Guidelines for Asymptomatic Patients== | ==Guidelines for Asymptomatic Patients== |
Revision as of 15:41, 17 January 2013
For patient information, click here
Chronic stable angina Microchapters | ||
Classification | ||
---|---|---|
| ||
| ||
Differentiating Chronic Stable Angina from Acute Coronary Syndromes | ||
Diagnosis | ||
Alternative Therapies for Refractory Angina | ||
Discharge Care | ||
Guidelines for Asymptomatic Patients | ||
Case Studies | ||
Chronic stable angina On the Web | ||
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Vijay Kunadian, M.D., Ph.D.; Smita Kohli, M.D.; Lakshmi Gopalakrishnan, M.B.B.S.
Synonyms and keywords: Stenocardia; angina pectoris; angor pectoris
Overview
Historical Perspective
Classification
Classic: Chronic Stable Angina
Atypical: Walk through Angina | Mixed Angina | Nocturnal Angina | Postprandial Angina | Syndrome X | Vasospastic Angina
Differentiating Chronic Stable Angina from Acute Coronary Syndromes
Pathophysiology
Epidemiology and Demographics
Risk Stratification
ECG/Chest X-Ray | Rest LV Function | Exercise Treadmill Test | Stress Imaging in Patients who are Able to Exercise | Stress Imaging in Patients who are Unable to Exercise | Coronary Angiography
Pretest Probability of CAD in the Patient with Angina
Prognosis
Diagnosis
History and Symptoms | Physical Examination | Test Selection Guideline for the Individual Basis | Laboratory Findings | Electrocardiography | Exercise ECG | Chest X-Ray | Myocardial Perfusion Scintigraphy with Pharmacologic Stress | Myocardial Perfusion Scintigraphy with Thallium | Echocardiography | Exercise Echocardiography | Positron Emission Tomography | Ambulatory ST Segment Monitoring | Electron Beam Tomography | Cardiac Magnetic Resonance Imaging | Coronary Angiography
Treatment
- Antiplatelet agents: Aspirin | Dipyridamole | Clopidogrel
- Antianginal agents: Nitrates | Beta Blockers | Calcium Channel Blockers | Potassium Channel Openers | Newer Anti-anginal Agents
Revascularization: PCI | CABG | Guidelines for Revascularization
- PCI vs Medical Therapy | CABG vs Medical Therapy | PCI and CABG versus Medical Therapy | PCI vs CABG
Alternative therapies for refractory angina: Transmyocardial Revascularization (TMR) | Spinal Cord Stimulation (SCS) | Enhanced External Counter Pulsation (EECP) | ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina
Discharge Care
Patient Follow-Up | Rehabilitation
Secondary Prevention
Smoking Cessation | Weight Management | Physical Activity | Lipid Management | BP Control | Diabetes Control | Influenza Vaccination | ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction
Guidelines for Asymptomatic Patients
Noninvasive Testing in Asymptomatic Patients | Coronary Angiography in Asymptomatic Patients | Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients
Related Chapters
- Exercise stress testing
- Exercise Tolerance Test Time as an Endpoint for Clinical Trials Evaluating Therapies for Refractory Angina
- For other uses of the term angina: Abdominal angina, Ludwig's angina, Prinzmetal's angina, Vincent's angina, or Angina tonsillaris
Landmark Trials
Textbook: COURAGE
Video: Dr. C. Micheal Gibson and lead author William Boden debate the results of COURAGE
Slides:
- Results of the COURAGE trial in english
- Results of the COURAGE trial in spanish
- Results of the economic substudy of the COURAGE trial
- Dr. Dean Kereiakes offers a critique of the COURAGE trial
- Dr. Duane Pinto puts the COURAGE results into perspective